Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating expenses:        
Research and development $ 59,877 $ 53,538 $ 179,096 $ 154,457
General and administrative 14,829 19,018 48,259 61,525
Total operating expenses 74,706 72,556 227,355 215,982
Loss from operations (74,706) (72,556) (227,355) (215,982)
Interest and other income, net 364 661 2,049 3,502
Loss before provision for income taxes (74,342) (71,895) (225,306) (212,480)
Provision for income taxes 6 0 7 0
Net loss (74,348) (71,895) (225,313) (212,480)
Other comprehensive gain:        
Unrealized (loss) gain on available-for-sale securities (283) 60 307 573
Comprehensive loss $ (74,631) $ (71,835) $ (225,006) $ (211,907)
Net loss per common share:        
Basic and diluted net loss per common share $ (0.92) $ (1.31) $ (3.21) $ (4.32)
Weighted-average shares outstanding used to calculate basic and diluted net loss per common share 81,176 54,920 70,170 49,176